Paul A. Calvo

Paul A. Calvo, Ph.D., is a director at Sterne, Kessler, Goldstein & Fox in the firm's Biotechnology & Chemical Practice Group. His practice is focused on the life sciences sector, where he counsels biotechnology and pharmaceutical companies on global patent strategy. Dr. Calvo's technical specialties include large molecule therapeutics such as antibodies, polypeptide therapeutics, antibody-drug conjugates, genomics, and bioproduction methods. He advises a diverse client base, from start-up companies to established international corporations, on matters including patent procurement, freedom-to-operate, and due diligence investigations.

Based on the single tracked case, Dr. Calvo has represented plaintiffs in patent litigation; in Biocon Biologics, Inc. et al. v. Regeneron Pharmaceuticals, Inc., he served as counsel for the plaintiff. However, his broader practice involves counseling both innovator and biosimilar companies, suggesting a more balanced practice that is not limited to one side. His firm biography notes his experience in enforcement matters and oppositions, and his work with clients on developing patent portfolios and design-around strategies. The firm's materials also highlight its significant practice before the Patent Trial and Appeal Board (PTAB), particularly in life sciences, which aligns with Dr. Calvo's focus.

Dr. Calvo has been with Sterne, Kessler, Goldstein & Fox for the duration of his legal career. Representative matters include his role as U.S. counsel to Merus B.V., where he developed a protection strategy for their antibody pipeline ahead of their acquisition by Genmab, and his long-term counsel to OncoMed Pharmaceuticals from its inception through its public offering. His writings focus on global patent prosecution and due diligence in life sciences venture investments.

Dr. Calvo earned his J.D. from The Catholic University of America's Columbus School of Law. He holds a Ph.D. in molecular and cell biology from the Medical College of Pennsylvania – Hahnemann University and a B.S. in biology from the University of Scranton. His technical experience prior to law includes post-doctoral fellowships at the University of Pennsylvania and the National Institutes of Health.